Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update focused on optimizing retention, duration, and discontinuation strategies for pharmacotherapy in opioid use disorder; currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Opioid Use Disorder (OUD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING